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Abstract
The Cu(II) and Ag(I) complexes, [Cu(phendio)3](ClO4)2·4H2O and [Ag(phendio)2]ClO4 (phendio = 1,10-
phenanthroline-5,6-dione), are prepared in good yield by reacting phendio with the appropriate metal perchlorate
salt. The X-ray crystal structure of the Ag(I) complex shows it to have a pseudo tetrahedral structure. ‘Metal-free’
phendio and the Cu(II) and Ag(I) phendio complexes strongly inhibit the growth of the fungal pathogen Candida
albicans, and are more active than their 1,10-phenanthroline analogues. The simple Ag(I) salts, AgCH3CO2,
AgNO3 and AgClO4.H2O display superior anti-fungal properties compared to analogous simple Cu(II) and Mn(II)
salts, suggesting that the nature of the metal ion strongly influences activity. Exposing C. albicans to ‘metal-free’
phendio, simple Ag(I) salts and [Ag(phendio)2]ClO4 causes extensive, non-specific DNA cleavage. ‘Metal-free’
phendio and [Ag(phendio)2]ClO4 induce gross distortions in fungal cell morphology and there is evidence for dis-
ruption of cell division. Both drugs also exhibit high anti-cancer activity when tested against cultured mammalian
cells.
Introduction
The yeast Candida albicans is an opportunistic fungal
pathogen and causes a range of diseases in suscept-
ible individuals (Pfaller et al. 1998). These can range
from superficial infections involving the oral cavity,
vagina or skin to severe life-threatening infections in-
volving many essential organs. In recent years there
has been a considerable increase in the incidence
of disease attributable to this yeast, with the spread
of AIDS, the widespread use of immuno-suppressive
therapy and the prolonged survival of patients with
critical illnesses (Lunel et al. 1999). Conventional
therapy for the control of fungal infections relies upon
the use of polyene (e.g. amphotericin B) and azole
(e.g. ketoconazole) drugs. However, the emergence of
C. albicans isolates resistant to these drugs has ser-
ious implications for the continued success of these
prescription anti-fungal compounds (Van den Bossche
et al. 1998; Kontoyiannis & Lewis 2002).
Metal-based drugs represent a novel group of anti-
fungal agents with potential applications for the con-
trol of fungal infections. 1,10-Phenanthroline (phen)
(Figure 1) and substituted derivatives, both in the
metal-free state and as ligands co-ordinated to trans-
ition metals, disturb the functioning of a wide vari-
ety of biological systems (Butler et al. 1969). Fur-
thermore, when the metal-free N,N′-chelating bases
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Fig. 1. Structures of phen and phendio.
are found to be bioactive it is usually assumed
that the sequestering of trace metals in situ is in-
volved, and that the resulting metal complexes are
the active species (MacLeod, 1952; Dwyer et al.
1969). Previous work has demonstrated that in
RPMI (Roswell Park memorial Institute) medium at
37 ◦C themetal-based drugs [Cu(phen)2(mal)] · 2H2O,
[Mn(phen)2(mal)] · 2H2O and [Ag2(phen)3(mal)] ·
2H2O (phen = 1,10-phenanthroline; malH2 =
malonic acid) inhibit the growth of C. albicans by
around 95% at a concentration of 5 μg/ml (McCann
et al. 2000; Coyle et al. 2003a). It was established that
both metal-free phen and the metal-phen complexes
affect mitochondrial function, retard the synthesis of
cytochromes b and c and uncouple respiration. Treat-
ment of fungal cells with the Cu(II) and Ag(I) com-
plexes resulted in a reduced amount of ergosterol in
the cell membrane and subsequent increase in its per-
meability. Cells exposed to metal-free phen and the
Cu(II) and Mn(II) complexes (but not the Ag(I) com-
plex) demonstrated an elevation in oxygen uptake.
The general conclusion was that the drugs damage
mitochondrial function and uncouple respiration. Fur-
thermore, the fact that the drugs were not uniformly
active suggested that their bioactivity had a degree of
metal-ion dependency.
In an attempt to enhance the anti-Candida activ-
ity of this class of phenanthroline drug current
efforts have focused on the phenanthroline deriv-
ative 1,10-phenanthroline-5,6-dione (phendio) (Fig-
ure 1) and its Ag(I) and Cu(II) complexes. The
phendio ligand, which has been known since 1947
(Smith & Cagle 1947), has two chelating func-
tionalities, the quinonoid and the diimine (the
N and O atoms are both sp2 hybridised). The
Cu(II) bis- and tris-N,N′ chelated phendio complexes,
[Cu(phendio)2][PF6]2·2H2O (Goss & Abruña 1985)
and [Cu(phendio)3](ClO4)2·2H2O·2MeCN (Liu et al.
2000), have been synthesized and the latter struc-
turally characterized. The complex was repor-
ted to have an approximately ideal octahedral
configuration with little static Jahn-Teller distor-
tion. The structure of the five-coordinate complex
[CuCl(phendio)2][PF6]·H2O has recently been pub-
lished (Yamada et al. 2002) and the mixed phen-
dio/phen species [Cu(phendio)(phen)]2+ has been
synthesized (Wu et al. 2002). The preparations of
Fe(II), Ru(II), Os(II), Co(II), Ni(II), Cu(I) and Zn(II)
complexes incorporating phendio have also been doc-
umented (Goss & Abruña 1985; Lei et al. 1996;
Eckert et al. 1982). The O,O′-bonded Pt(0) com-
plex [Pt(phendio)(PPh3)2] and the N,N′-bonded Pd(II)
complex [Pd(phendio)Cl2] are also known (Girgis
et al. 1975), as are heterobimetallic (Pt/Pd, Pt/Ru) spe-
cies which use both of the O,O′ and N,N′ donor sets of
the phendio ligand (Fox et al. 1991; Paw & Eisenberg
1997). In addition, an assortment of mononuclear, ho-
mobinuclear and heterobinuclear phendio complexes
with Group 4 and 5 metals in both low and high ox-
idation states have been synthesized (Calderazzo et al.
1999).
Materials and methods
Chemistry
Chemicals were purchased from commercial sources
and, unless specified, were used without further puri-
fication. Phendio, which was essentially insoluble in
water, was prepared in accordance with the literat-
ure method (Yamada et al. 1992). Infrared spectra of
solids (in a KBr matrix) were recorded in the region
4000–400 cm−1 on a Nicolet FT-IR Impact 400D in-
frared spectrometer. Cyclic voltammetry experiments
were preformed using a low noise potentiostat (Biostat
II, Electrochemical and Medical systems, Newbury,
UK). Data acquisition was carried out using a Gate-
way GP6-350 computer, a Powerlab\400 interface
system (AD Instruments Ltd, East Sussex, UK) and
Echem for Windows software (AD Instruments Ltd).
The Pt disk working electrode (5 cm length) was made
from Teflon-insulated platinum/iridium (90%/10%)
wire (125 μm bare diameter, 160 μm coated dia-
meter (5T) obtained from Advent Research Materials,
Suffolk, UK). A silver wire and a saturated calomel
electrode (SCE) were used as the auxiliary and refer-
ence electrode, respectively. Fresh solutions (1 mmol)
of the complexes were made up in the supporting
electrolyte solution {0.1 mol dm−3 solution of tet-
raethylammonium perchlorate (TEAP) in dry, purified
MeCN}. For reasons of water-insolubility voltammo-
grams of [Ag(phen)2]ClO4 were run in DMF/TEAP.
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The complex solutions were deaerated with O2-free
N2 for 20 min prior to each experiment and cycles
were run at a scan rate of 100 mV s−1. Potentials
are reported with respect to the SCE. Microanalytical
data were provided by the Microanalytical Laboratory,
National University of Ireland, Cork, Ireland.
[Cu(phendio)3](ClO4)2 · 4H2O
This complex was prepared, with improved yield,
using a slight modification of the procedure used
to synthesise [Cu(phendio)3](ClO4)2 · 2H2O · 2MeCN
(Liu et al. 2000). To a pale blue solution contain-
ing Cu(ClO4)2 · 6H2O (0.37 g, 1.0 mmol) in ethanol
(20 cm3) was added phendio (0.63 g, 3.0 mmol) and
the resulting green solution was stirred at room tem-
perature for 0.5 h. The precipitated green solid was
filtered off, washed with ethanol and ether and then
air-dried. The complex was soluble in water and in
ethanol. Yield: 0.74 g (77%). % Found: C, 44.93; H,
2.01; N, 8.74; % Calc: C, 44.85; H, 2.72; N, 8.71. IR
(KBr): 3445, 1707, 1640, 1584, 1486, 1436, 1313,
1264, 1104, 932,729, 630 cm−1.
[Ag(phendio)2]ClO4
The following synthesis was carried out in the absence
of light. To a solution of phendio (0.2 g, 1.0 mmol) in
ethanol (20 cm3) was added AgClO4 (0.1 g, 0.4 mmol)
and the resulting beige coloured solution was stirred
at 30 ◦C for 0.5 h. After cooling to room temperat-
ure the precipitated orange product was filtered off,
washed with small volumes of ethanol and ether, and
then air-dried (with light excluded). The solid was
recrystallised from hot acetonitrile and was not light-
sensitive. The complex was soluble in hot acetonitrile
and in DMSO, and was insoluble in water. Yield:
0.43 g (69%). % Found: C, 45.99; H, 1.91; N, 8.98;
% Calc: C, 45.96; H, 1.93; N, 8.93. IR (KBr): 3432,
1695, 1640, 1578, 1467, 1430, 1307, 1104, 929, 818,
735, 627 cm−1. NMR: 1H NMR (ppm DMSO): 8.85
(dd, 2H), 8.46 (dd, 2H), 7.72 (dd, 2H).
[Ag(phen)2]ClO4
This complex was prepared using a modifica-
tion of the literature procedure employed to make
[Ag(phen)2]NO3 · H2O (Murtha & Walton 1973). All
operations were conducted in the absence of light.
To a solution containing 1,10-phenanthroline (0.54 g,
3 mmol) in 20 cm3 of ethanol, AgClO4 (0.2 g, 1 mmol)
was added. The yellow solution was refluxed for 0.5 h
Table 1. Crystal data and structure refinement for
[Ag(phendio)2]ClO4.
Empirical formula C24H12AgClN4O8
Formula weight 627.70
Temperature 150(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group 2cm C2/c
Unit cell dimensions a = 13.069(5) Å α = 90◦.
b = 12.209(4) Å β = 108.334(4)◦ .
c = 14.517(5) Å γ = 90◦.
Volume 2198.7(13) Å3
Z 4
Density (calculated) 1.896 Mg/m3
Absorption coefficient 1.102 mm−1
F(000) 1248
Crystal size 0.35 × 0.23 × 0.17 mm3
Theta range for data collection 2.34 to 25.00◦.
Index ranges −15<=h<=15, −14<=k<=14, −17<=l<=17
Reflections collected 7375
Independent reflections 1941 [R(int) = 0.0453]
Completeness to theta = 25.00◦ 99.9 %
Absorption correction Multiscan
Max. and min. transmission 1.00000 and 0.553911
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 1941 / 0 / 186
Goodness-of-fit on F2 1.070
Final R indices [I>2sigma(I)] R1 = 0.0379, wR2 = 0.0966
R indices (all data) R1 = 0.0461, wR2 = 0.1032
Largest diff. peak and hole 1.617 and −1.041 e.Å−3
Table 2. Selected bond lengths [Å] and angles [◦] for
[Ag(phendio)2]ClO4.
Ag(1)-N(2) 2.347(3)
Ag(1)-N(1) 2.362(3)
Ag(1)-O(2)#1 3.329(3)
N(2)-Ag(1)-N(2)#2 119.05(13)
N(2)-Ag(1)-N(1)#2 157.36(10)
N(2)-Ag(1)-N(1) 70.33(10)
N(2)#2-Ag(1)-N(1) 157.36(10)
N(1)#2-Ag(1)-N(1) 109.36(14)
N(2)-Ag(1)-O(2)#1 126.29(8)
N(1)-Ag(1)-O(2)#1 70.09(8)
N(2)-Ag(1)-O(2)#3 89.08(8)
N(1)-Ag(1)-O(2)#3 71.58(8)
Symmetry transformations used to generate equivalent
atoms: #1 x−1/2,−y+3/2,z−1/2 #2 −x,y,−z+3/2 #3
−x+1/2,−y+3/2,−z+2
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and allowed cool. The yellow precipitate was filtered
and washed with small volumes of ethanol and ether
and air dried in darkness. This complex was insol-
uble in water and all common organic solvents. Yield:
0.40 g (70%). % Found: C, 51.08; H, 2.82; N, 9.90;
% Calc: C, 50.77; H, 2.84; N, 9.90. IR (KBr): 3432,
3075, 1621, 1584, 1516, 1430, 1338, 1147, 1092, 843,
760, 723, 624 cm−1.
X-ray crystallography
Crystal data for [Ag(phendio)2]ClO4 are summar-
ized in Table 1. Data were collected using a Bruker
SMART1000 diffractometer and the structure was
solved by Patterson methods and refined by full-
matrix least-squares on F2 using all the data (Sheldrick
2001). All non-hydrogen atoms were refined with an-
isotropic atomic displacement factors and hydrogen
atoms attached to carbon were inserted at calculated
positions.
Supplementary data for [Ag(phendio)2]ClO4 are
available from the Cambridge Crystallographic Data
Centre, 12 Union Road, Cambridge CB2 1EZ, Eng-
land (Fax: +44-1223-336033), on request quoting the
deposition number CCDC 212685.
Anti-fungal susceptibility testing
C. albicans ATCC 10231 was obtained form the
American Type Culture Collection, (VA., U.S.A.).
Cultures were grown on Sabouraud dextrose agar
(SDA) plates at 37 ◦C and maintained at 4 ◦C for short-
term storage. Cultures were routinely sub-cultured
every 4–6 weeks. Cultures were grown to the sta-
tionary phase (approximately 1×108 cells cm−3)
overnight at 30 ◦C and 200 rpm in minimal medium
(MM) (2% w/v glucose, 0.5% w/v yeast nitrogen base
(without amino acids or ammonium sulphate), 0.5%
w/v ammonium sulphate). Solutions of the water-
soluble complex [Cu(phendio)3](ClO4)2 · 4H2O were
prepared by dissolving the complex (0.02 g) in dis-
tilled water (100 cm3) to yield a stock solution with
a concentration of 200 μg cm−3. Doubling dilutions
of this stock solution were made to yield a series
of test solutions. The water-insoluble Ag(I) com-
plexes, [Ag(phendio)2]ClO4 and [Ag(phen)2]ClO4,
were made up as suspensions (0.02 g) in water
(100 cm3) to give stock suspensions. With vigorous
agitation of these suspensions doubling dilutions were
made to give a series of test suspensions. Minimum in-
hibitory concentrations (MIC’s) were then determined
using the broth microdilution method (McCann et al.
2000).
Extraction of DNA from C. albicans
Yeast cells were grown in the presence of drug
(10 μg cm−3) to the late exponential phase (18–
24 h) in minimal medium at 30 ◦C in an orbital in-
cubator. Cells were harvested by centrifugation and
washed with 1 mM EDTA. Cells were resuspended
in spheroplasting buffer (1 M sorbitol, 0.1 M EDTA,
6 mg cm−3 lyticase and 0.05 M dithiotheritol, pH 7.5)
and incubated at 37 ◦C for 2 h. Spheroplasts were
harvested by centrifugation, resuspended in lysing
buffer (50 mM EDTA, 50 mM Tris (pH 8), 1% w/v
SDS and 8 μg cm−3 proteinase K) and incubated
at 65 ◦C for 0.5 h. DNA was precipitated with two
volumes of chilled ethanol (95% v/v) and incubated
at −20 ◦C overnight. DNA was harvested by centrifu-
gation, washed with ethanol (20% v/v), removed by
centrifugation at 4000 × g for 25 min and allowed air
dry. The DNA was resuspended in TE buffer (5.4%
w/v Tris HCl, 2.75% w/v boric acid, 20 cm3 0.5 M
EDTA (pH 8.0)), 1 mg cm−3 RNase and incubated at
37 ◦C for 0.5 h. Ethanol (95% v/v) and 3 M sodium
acetate solution (pH 5.2) was added and the sample
stored at −20 ◦C overnight.
Purity and concentration of DNA was determined
by UV spectroscopy (260–280 nm). DNA damage was
assessed using gel electrophoresis. DNA from yeast
cells was run at a concentration of 40 μg cm−3 on a
0.8% (w/v) agarose gel at 40 V for 18 h. Following
staining with ethidium bromide DNA was visualised
using a UV transilluminator.
Electron microscopy of yeast cells
Primary fixation of stationary phase yeast cells was in
a 3% solution of gluteraldehyde in 0.1 M phosphate
buffer for 2 h. Secondary fixation was in a 2% solution
of osmium tetroxide in 0.1 M phosphate buffer for 1 h.
Dehydration of samples was in an alcohol series of
10%, 30%, 50%, 75%, 95% and 100% v/v, each for
15 min. Samples were embedded in Agar 100 resin
(Agar Scientific Ltd., U.K.) and viewed using a Hita-
chi H-7000 Transmission Electron Microscope (TEM)
operating at 100Kv accelerating voltage.
In vitro toxicity testing on mammalian cells
Sub-confluent DLKP cells were harvested by trypsin-
isation, washed and resuspended in phosphate buf-
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Fig. 2. X-ray crystal structure of [Ag(phendio)2]ClO4.
Fig. 3. Intermolecular and π–π stacking interactions in the struc-
ture of [Ag(phendio)2]ClO4.
fered saline (PBS, pH 7.2). Cells were enumerated
microscopically and diluted with Minimal Essential
Medium (MEM, Sigma Aldrich Chemical Co., UK)
to give a final cell density of 2×104 cm−3. Ninety
six well plates (NUNC) were seeded with 100 μl of
this suspension per well and incubated at 37 ◦C in a
humidified atmosphere (5% CO2) for 24 h to allow
cell attachment. Water-insoluble metal-free phendio
and [Ag(phendio)2]ClO4 were first dissolved in the
minimum amount of DMSO and the resulting stock
solution diluted in growth medium until the DMSO
concentration was approximately 1%. A range of con-
centrations of the drugs were added to the rows of
wells and the plates were re-incubated until controls
reached 80–90% confluency (typically 5–6 days). Cell
growth in toxicity assays was quantified as described
previously (Martin & Clynes 1993).
Results and discussion
Chemical synthesis and structure
[Cu(phendio)3](ClO4)2 · 4H2O and [Ag(phendio)2]ClO4
were prepared in good yield by reacting phendio with
the appropriatemetal perchlorate salt. The Cu(II) com-
plex has previously been made (Liu et al. 2000) and
the purpose of the present synthesis was to procure a
sample of the complex for anti-fungal testing.
The X-ray crystal structure of the metal-free phen-
dio ligand has recently been published (Calderazzo
et al. 1999) and shows the molecule to be almost
planar and stacked by pointing their O atoms in
opposite directions. The X-ray crystal structure of
[Ag(phendio)2]ClO4 is shown in Figure 2 and import-
ant bond lengths and angles are given in Table 2. The
metal lies in a pseudo tetrahedral environment and is
ligated by the four nitrogens of two phendio ligands.
There is a 2-fold axis passing through the silver ion
and the uncoordinated perchlorate is disordered about
the axis (the Cl is not exactly on the axis). There are
longer interactions between the metal and the O(2)
atoms of neighbouringmolecules (Figure 3) so that the
cations form 1-dimensional chains through the struc-
ture. In addition, there is a significant amount of π–π
stacking also present throughout the unit cell (inter-
planar distance for the π–π stacking is 3.32 Å). The
basic structure of [Ag(phendio)2]ClO4 is similar to
those reported for [Ag(dmphen)2][BF4] · CH2Cl2 and
[Zn(dmphen)2][BF4]2 (dmphen = 2,9-dimethyl-1,10-
phenanthroline) (Pallenberg et al. 1997).
Cyclic voltammetry data for metal-free phen-
dio, [Ag(phendio)2]ClO4, [Ag(phen)2]ClO4 and some
simple Ag(I) salts are listed in Table 3. All of the
silver-containing species showed a single, irrevers-
ible cathodic wave for the reduction process Ag+
→ Ag0 and also a large anodic stripping peak for
the reoxidation of the plated silver metal (Ag0 →
Ag+). With respect to metal deposition it has been
reported (Lei et al. 1996) that the Cu(II) complex
[Cu(phendio)2]2+ gets reduced to Cu(I) at slightly less
negative pots than that required to reduce the phendio
ligand, and that copper metal plating on the electrode
surface was frequently observed. Allowing for the
differences in solvent (DMF and MeCN) it is inter-
esting that reduction of Ag+ to Ag0 was more facile
for [Ag(phendio)2]ClO4 than for [Ag(phen)2]ClO4
suggesting that the N atoms of the phen ligand are
stronger electron donors than those of phendio. This
fact is substantiated by data derived from studies of
pKa and metal ion binding constants for protonated
phen and phendio, which showed that the carbonyl
oxygens on the latter molecule lessen the electron
density on the N atoms of the pyridine rings (Eck-
ert et al. 1982). Furthermore, binding constants with
the divalent metal ions, Zn(II), Co(II) and Ni(II) are
known to be 2-6 orders of magnitude larger for phen
than for phendio.
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Table 3. Cyclic voltammetry data (potentials in mV v’s SCE).a
Ag+ → Ag0 Ag0 → Ag+ phendio (E1/2)A phendio (E1/2)B
AgCH3CO2 +25 +282
AgNO3 +134 +310
AgClO4 +152 +288
[Ag(phen)2]ClO4 −100 +482
phendio −471 −1042
[Ag(phendio)2 ]ClO4 +8 +298 −475 −1039
a[Ag(phen)2]ClO4 was run in DMF/TEAP and all other samples were run in MeCN/TEAP.
Unlike metal-free phen, which is electroinactive
in the potential region +1000 to −1000 mV (versus
SCE), an MeCN solution of uncomplexed phendio
showed two, reversible, one-electron waves (A and B)
with half-wave potential values of (E1/2)A = −471 mV
and (E1/2)B = −1042 mV. This behavior is very sim-
ilar to that previously reported (Eckert et al. 1982;
Eckert & Bruice 1983; Goss & Abruña 1985; Hilt
et al. 1982) for phendio in aprotic solvents, with
the quinone being reduced firstly to the semiquinone
(wave A) and then to the hydroquinone (wave B).
Presumably, the protons required for these conver-
sions are derived from traces of water in the MeCN
solvent. The voltammogram of [Ag(phendio)2]ClO4
(Figure 4) shows the plating and stripping peaks for
the metal and also the two sets of reversible, one-
electron waves (A and B) for the phendio ligand,
the E1/2 values of the ligand redox waves being es-
sentially the same as that of the metal-free phendio
ligand. Thus, upon electrochemical reduction of the
Ag+ center in [Ag(phendio)2]ClO4 the resulting Ag0
metal atom dissociates from the phendio ligand and
this metal-free ligand then exhibits its normal two,
Nernstian, one-electron redox waves.
Effect of drugs on fungal cell growth
MIC values for in vitro anti-Candida susceptibility
testing are displayed in Table 4. In the first instance,
‘metal-free’ phendio is a more active drug than ‘metal-
free’ phen. As previously suggested for ‘metal-free’
phen (McCann et al. 2000; Coyle et al. 2003a) it is
thought that the biologically active form of chelating
1,10-phenanthroline-type ligands is an in situ gener-
ated metal complex of the ligand. The Cu(II) and Ag(I)
complexes incorporating the phendio ligand are signi-
ficantly more active than the most active phen com-
plex, [Ag2(phen)3(mal)]·2H2O (Coyle et al. 2003a).
The results for ‘metal-free’ phendio and the Cu(II)
Fig. 4. Cyclic voltammogram of [Ag(phendio)2]ClO4.
and Ag(I) complexes suggest that the two carbonyl
appendages on the phenanthroline skeleton of the lig-
and play an important role in its biochemical activity.
It is envisaged that the carbonyl oxygens might of-
fer points of secondary interactions with fungal cell
biomolecules containing electron-acceptor sites (e.g.
polar Hδ+ sites and other metal cations). In addition,
the more facile electrochemical activity of the phendio
ligand, compared to that of phen, opens up the possib-
ility for phendio to participate destructively in cellular
redox reactions.
As the simple Ag(I) salts, AgCH3CO2, AgNO3
and AgClO4 · H2O are substantially superior anti-
Candida drugs than analogous simple Cu(II) and
Mn(II) salts (Geraghty et al. 2000) this implies that
the type of metal ion greatly influences activity, with
Ag(I) being particularly active. In this respect tetra-
hedral bis-diphosphine Ag(I) complexes have previ-
ously been shown to exhibit good anti-Candida and
anti-cancer activity. (Berners-Price et al. 1988). Free
Ag(I) ions are also known to be strongly fungicidal,
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algicidal and bactericidal at comparatively low doses
(Ratte 1999). The use of silver preparations in medi-
cine and for sterilizing potable or swimming-pool
water is based on a particular sensitivity of bacterial
metabolism to Ag(I)-inhibiting thiol enzymes. Tilton
and Rosenberg (Tilton & Rosenberg 1978) proposed
three possible mechanisms for bacterial growth inhib-
ition by Ag(I): interference with electron transport,
binding to DNA and interaction with the cell mem-
brane. A bactericidal effect has been reported for both
metallic silver and Ag(I) salts, with the concentration
of the metal ion being responsible for the disinfection
capability (Thurman & Gerba 1989). Both AgNO3
and the Ag(I) complex of 4-amino-N-2-pyrimidinyl-
benzenesulfonamide (commercially available as the
cream silvadene or flamazine) and used topically to
prevent infections in cut and burn wounds) inhibit
the activity of isolated fungal (C. albicans) and hu-
man phosphomannose isomerases (PMI). PMI are
Zn(II)-containing metalloenzymes which catalyse the
reversible interconversion of fructose 6-phosphate and
mannose 6-phosphate (Wells et al. 1995). It was postu-
lated that enzyme inhibition is due to binding of Ag+
to either the imidazole N of histidine or to a free S
on cysteine. Whereas the Ag(I)-sulfonamide complex
showed little or no discrimination between fungal and
human PMI AgNO3 was more active against the lat-
ter enzyme. An in vivo study, which monitored the
mortality in burned mice infected with Pseudomo-
nas aeruginosa and treated with an oil/water cream
containing an Ag+ complex, showed that survival
numbers were less for animals treated topically with
AgNO3 than for those with silvadene (Bult et al.
1981). However, no obvious relationships were found
between the antibacterial activity and selected phys-
ical properties (stability constant, water solubility and
conductivity) of the Ag(I) species. In the same study
it was tentatively concluded that AgNO3 was active
in vivo as a consequence of the relatively high con-
centration of free Ag+ ion formed upon dissolution
of the salt. Given the very low water solubility of
silvadene its good in vivo activity was attributed to
the interaction of the whole molecule with the mi-
croorganism. If the above arguments are applied to
the present results then it would seem that in the
case of the simple Ag(I) salts, such as AgNO3, the
anti-Candida activity is due to the bioavailability of
a relatively large concentration of Ag(I) ions. With
the very potent, yet poorly water-soluble complexes,
[Ag2(phen)3(mal)]·2H2O and [Ag(phendio)2]ClO4, it
seems that their activity is due to the whole mo-
Fig. 5. DNA banding pattern of C. albicans cells treated with
marker, control, phendio, AgClO4. [Ag(phendio)2]ClO4. Lane 1:
Molecular weight marker; Lane 2: Control; Lane 3: phendio; Lane
4: AgClO4; Lane 5: [Ag(phendio)2]ClO4.
lecule. In the case of the highly water-insoluble
complex [Ag2(imppn)4](ClO4)2 (imppn= (Z)-3-(1H -
imidazol-1-yl)-2-phenylpropenenitrile) its poor anti-
Candida activity is a feature of the whole molecule
(McCann et al. 2003).
Effect of drugs on the integrity of fungal nuclear DNA
The effects of selected Ag(I) complexes and simple
Ag(I) salts on the integrity of fungal nuclear DNA
was investigated and compared to that of a non-drug-
treated control. C. albicans exposed to metal-free
phendio, AgClO4 · H2O and [Ag(phendio)2]ClO4
showed extensive smearing of DNA, indicating non-
specific cleavage of the DNA (Figure 5). AgCH3CO2,
AgNO3 and [Ag2(phen)3(mal)] · 2H2O have previ-
ously been shown to have a similar effect on the fungal
DNA (Coyle et al. 2003b),. In contrast, the metal-
metal bonded dimer, [Ag2(imppn)4](ClO4)2 (McCann
et al. 2003), which does not contain a chelating
phen-type ligand and has only marginal anti-Candida
activity, did not disrupt the fungal DNA. From stud-
ies of nucleic acid-Ag(I) interactions, conducted using
isolated calf thymus DNA (Nordén et al.1986) and
the free purine and pyrimidine bases found in DNA
(Šponer et al. 1999; Nordén et al. 1986), there was
compelling evidence for complexation of the metal
with N atoms of the bases. However, in contrast to the
present experiments, which show extensive disruption
ofCandidaDNA by Ag(I) simple salts and complexes,
results with the calf thymus DNA indicated that only
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Fig. 6. Electron micrographs of C. albicans cells grown in the absence of drug (a) and (b), and in the presence of phendio (c and d) and
[Ag(phendio)2]ClO4 (e and f).
relatively minor structural changes occurred upon ex-
posure to Ag(I) ions (swelling at some base pair sites
by coordination of the Ag(I) and reorientation of the
DNA molecule into a strongly tilted conformation)
(Nordén et al. 1986).
Effect of drugs on the internal structure of C. albicans
Cultures of C. albicans were grown to the stationary
phase overnight in MM at 30 ◦C and 200 rpm in the
presence of phendio and [Ag(phendio)2]ClO4 at a final
drug concentration of 10 μg cm−3. Cells were harves-
ted by centrifugation, washed with PBS (pH 7.2) and
placed on ice prior to preparation for TEM examina-
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tion (as described above). Cells grown in the absence
of drug showed normal cellular morphology. A high
percentage (>70%) of budding cells were present in
the population and all cells possessed a distinct cell
wall, an intact nucleus and numerous membranous or-
ganelles (Figure 6a and 6b). In contrast, cells grown
in the presence of metal-free phendio were signific-
antly larger (see scale bars on figures) than cells grown
in drug-free medium and they also lacked buds (Fig-
ure 6c and 6d). This indicated a possible drug-induced
circumvention of the control of cell division. In addi-
tion, the cells exhibited a diffuse cell wall, ruptured
internal organelles, the withdrawal of the cytoplasmic
membrane from within the cell wall and an enlarged
nucleus. Cells treated with [Ag(phendio)2]ClO4 had a
distended cell wall, ruptured membranous organelles
and, in some cases, a fragmented nucleus (Figure 6e).
In addition, there was also evidence of withdrawal of
the cytoplasmic membrane from within the cell wall
(Figure 6f). Once again, the lack of buds suggests an
interference in the process of cell division.
Previous work has demonstrated that [Ag2(phen)3
(mal)] · 2H2O has a profound effect on the physiology
of C. albicans by lowering the respiration rate which,
in turn, leads to a depletion of ergosterol in the
fungal cell membrane (Coyle et al. 2003a). Recently
it has been established that this Ag(I) complex in-
duces many of the morphological changes evident
in cells treated with [Ag(phendio)2]ClO4 and it also
causes extensive, non-specific DNA fragmentation in
C. albicans (Coyle et al. 2003b). Examination of
the integrity of nuclear DNA following exposure of
cells to [Ag(phendio)2]ClO4 indicates that this com-
plex is capable of inducing non-specific DNA cleav-
age, a feature which is also analogous to the cell
death pathway evidenced in C. albicans exposed to
[Ag2(phen)3(mal)] · 2H2O. This ability to splinter
DNA may be responsible for the appearance of nuc-
lear fragments evident in the electron-micrographs
(Figure 6e).
Mammalian cell studies
Preliminary experiments on cultured human cancer
cells have produced IC50 values of 0.008 μg cm−3
(0.04 μM) and 0.025 μg cm−3 (0.40 μM) for metal-
free phendio and [Ag(phendio)2]ClO4, respectively.
Previous studies (Igdaloff et al. 1983) have shown that
phendio and its isomer, 1,7-phenanthroline-5,6-dione,
inhibit the growth of S49 mouse lymphona cells and
S110 mouse cells, with phendio being the most active
Table 4. MIC data for C. albicans {concentrations ex-
pressed as μM and as μg cm−3 (in brackets)}.
Compound MIC μM (μg cm−3)
AgCH3CO2 30 (5)
AgNO3 30 (5)
AgClO4.H2O 44 (10)
phen 14 (2.5)
phendio 3 (0.6)
[Cu(phendio)3(ClO4)2]·4H2O 1.3 (1.3)
[Ag(phendio)2 ]ClO4 0.5 (0.3)
[Ag(phen)2]ClO4 8.8 (5)
(EC50 S49 = 0.056μM; S110= 0.042μM). Although
it was postulated that inhibition of DNA and RNA syn-
theses were major components of the cytotoxic effects
the phenanthrolines were presumed to have more than
one mode of action. Futhermore, since the effects of
the two molecules on dXTP levels were qualitatively
different, the molecules probably differed in at least
one of their target sites. In this regard it was noted
that whereas phendio can chelate metal ions, the 1,7-
isomer is incapable of chelation (Igdaloff et al. 1983).
Conclusions
The Cu(II) and Ag(I) complexes, [Cu(phendio)3]
(ClO4)2 · 4H2O and [Ag(phendio)2]ClO4, can be
prepared in good yield, and the latter has a pseudo tet-
rahedral structure. ‘Metal-free’ phendio and the Cu(II)
and Ag(I) phendio complexes are potent anti-Candida
agents and are more active than their phen analogues,
suggesting an influential biochemical role for the car-
bonyl oxygen atoms of the phendio molecule. The
simple Ag(I) salts, AgCH3CO2, AgNO3 and AgClO4
· H2O, are much better anti-Candida drugs than ana-
logous simple Cu(II) and Mn(II) salts, suggesting that
the nature of the metal ion strongly influences activ-
ity. C. albicans exposed to metal-free phendio, simple
Ag(I) salts and [Ag(phendio)2]ClO4 experience ex-
tensive and non-specific DNA cleavage. ‘Metal-free’
phendio and [Ag(phendio)2]ClO4 cause gross distor-
tions in fungal cell morphology and there is evidence
for disruption of cell division. Both drugs also have
the ability to kill cultured mammalian cancer cells at
relatively low concentrations (IC50 = 0.008 μg cm−3
and 0.025 μg cm−3).
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